Pekayvaz, Kami https://orcid.org/0000-0003-4040-650X
Losert, Corinna https://orcid.org/0000-0002-5997-4702
Knottenberg, Viktoria
Gold, Christoph
van Blokland, Irene V.
Oelen, Roy https://orcid.org/0000-0002-5026-6531
Groot, Hilde E.
Benjamins, Jan Walter https://orcid.org/0000-0002-5701-0539
Brambs, Sophia
Kaiser, Rainer https://orcid.org/0000-0003-1750-3395
Gottschlich, Adrian https://orcid.org/0000-0002-2898-4182
Hoffmann, Gordon Victor
Eivers, Luke
Martinez-Navarro, Alejandro https://orcid.org/0000-0003-3893-1719
Bruns, Nils
Stiller, Susanne
Akgöl, Sezer https://orcid.org/0000-0002-3154-3214
Yue, Keyang
Polewka, Vivien
Escaig, Raphael
Joppich, Markus https://orcid.org/0000-0002-6665-8951
Janjic, Aleksandar
Popp, Oliver
Kobold, Sebastian https://orcid.org/0000-0002-5612-4673
Petzold, Tobias https://orcid.org/0000-0001-7805-5632
Zimmer, Ralf
Enard, Wolfgang
Saar, Kathrin https://orcid.org/0000-0002-4483-1557
Mertins, Philipp https://orcid.org/0000-0002-2245-528X
Huebner, Norbert https://orcid.org/0000-0002-1218-6223
van der Harst, Pim
Franke, Lude H.
van der Wijst, Monique G. P. https://orcid.org/0000-0003-1520-3970
Massberg, Steffen https://orcid.org/0000-0001-7387-3986
Heinig, Matthias https://orcid.org/0000-0002-5612-1720
Nicolai, Leo https://orcid.org/0000-0003-0776-5885
Stark, Konstantin https://orcid.org/0000-0002-5369-8399
Article History
Received: 2 May 2023
Accepted: 26 March 2024
First Online: 21 May 2024
Competing interests
: S.K. has received honoraria from TCR2, Novartis, BMS, Galapagos, Miltenyi and GSK. S.K. received license fees from TCR2 and Carina Biotech. A.G. received research support from Tabby Therapeutics for work unrelated to the paper. S.K. received research support from TCR2, Plectonic, Catalym and Arcus Bioscience for work unrelated to the paper. The other authors declare no competing interests.